Pub. Date : 2020 Nov
PMID : 32700645
8 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 2 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 3 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 4 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 5 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 6 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 7 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |
| 8 | The pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were separately as 87%, 98%, 34.78, 0.14, 256.41 and 0.98, indicating a very powerful differentiating ability of IL-2 for LTBI from non-TB controls.For differentiating ATB from LTBI, the pooled sensitivity, specificity, PLR, NLR,DOR and AUROCof IL-2 were 83%, 76%, 3.41, 0.22, 15.47 and 0.87, respectively, suggesting a good differentiating ability of IL-2.Conclusions: These findings showed that IL-2 is a powerful marker for differentiating LTBI from non-TB controls and a good marker for differentiating ATB from LTBI individuals. | Terbium | interleukin 2 | Homo sapiens |